This was what they did .... 4 groups (total n=2165) from 5 european countries:
1) low flux HD
2) high flux HD
3) low efficiency HDF
4) high efficiency HDF
.... it turned out that high-efficiency HDF had 35% lower mortality rates than low flux HD (p=0.01). These observational results suggest that HDF may improve patient survival independently of its higher dialysis dose .... but more randomised controlled trials are needed before clinical recommendation. but looks like HDF is the way to go ....
This was published 26th April last year.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment